miRNA expression profile as a potential tool for discrimination between bacterial and interstitial cystitis.

Area of Science:

• Urology
• Molecular Biology
• Immunology

Background:

• Interstitial cystitis (IC) is a chronic bladder inflammation with unknown causes and poorly understood mechanisms, presenting symptoms similar to bacterial cystitis (BC).
• Limited data exists on the role of regulatory microRNAs (miRNAs) in the pathogenesis of IC.
• Investigating miRNA expression differences can help distinguish IC from BC and elucidate IC mechanisms.

Purpose of the Study:

• To identify differentially expressed miRNAs between mouse models of IC and BC.
• To find potential miRNA biomarkers that can discriminate between IC and BC.
• To evaluate the utility of a mouse model for studying human IC pathogenesis.

Main Methods:

• Utilized mouse models for chronic aseptic cystitis (cyclophosphamide) and acute bacterial cystitis (E. coli).
• Selected and validated regulatory miRNAs based on human IC datasets using quantitative PCR on mouse bladder tissue.
• Performed enrichment analysis of miRNA target mRNAs to infer differing inflammatory mechanisms.

Main Results:

• Observed differential expression of 20 out of 33 selected miRNAs in IC and BC compared to controls.
• Identified 11 miRNAs with consistent expression trends between mouse and human IC.
• Found significant differences in bladder tissue between IC and BC models, identifying miR-301a-3p as a potential discriminatory marker and NKRF as a target gene.

Conclusions:

• miRNA expression, validated targets, and signaling pathways differ between IC and BC, potentially depending on the inflammation type.
• The mouse model of IC shares similarities with human IC, validating its use for identifying discriminatory biomarkers like miR-301a-3p.
• The study suggests potential therapeutic targets for IC, including NKRF and NF-κB pathways.